← Back to Clinical Trials
Recruiting NCT06906627

NCT06906627 Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06906627
Status Recruiting
Phase —
Sponsor Duke University
Condition Chronic Kidney Disease(CKD)
Study Type INTERVENTIONAL
Enrollment 750 participants
Start Date 2025-10-28
Primary Completion 2027-04-01

Trial Parameters

Condition Chronic Kidney Disease(CKD)
Sponsor Duke University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 750
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-10-28
Completion 2027-04-01
Interventions
(IRIS-CKD Screening Program): Home Kit(IRIS-CKD Screening Program): Standard Lab Order

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

Eligibility Criteria

Screening Program- Inclusion Criteria: * Adults with type 2 diabetes (T2D) * Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP). * Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR Exclusion Criteria: • Chronic kidney disease (CKD) diagnosis

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

VIEW ON CLINICALTRIALS.GOV ↗ MORE CHRONIC KIDNEY DISEASE(CKD) TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology